Status:
COMPLETED
COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Droplet Spread
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Measurement of aerosolisation during esophagogastroduodenoscopy (EGD) to compare two types of mouthpieces, conventional versus a new and commercially available one 'the droplet reduction mouthpiece B1...
Detailed Description
During esophagogastroduodenoscopy (EGD), a hard-plastic mouthpiece is used to protect the endoscope from being bitten and to enable its smooth insertion. In September 2020, the droplet reduction Mouth...
Eligibility Criteria
Inclusion
- Aged \>18 years old;
- Male or female patients;
- Patients undergoing elective standard diagnostic EGD;
- Negative polymerase chain reaction (PCR) test on nasopharyngeal swab 24 or 48 hours prior to the test;
- No anatomical deformity of nose and throat, no known diseases of nose and throat;
- Signed informed consent
Exclusion
- Females who are pregnant or lactating.
Key Trial Info
Start Date :
March 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04864015
Start Date
March 17 2021
End Date
June 30 2021
Last Update
October 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven
Leuven, Flemish Brabant, Belgium, 3000